ReNeuron Group plc
13 February 2007
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
(1). Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):
RENEURON GROUP PLC
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights: ( X )
An acquisition or disposal of financial instruments which may result
in the acquisition of shares already issued to which voting rights are
attached: ( )
An event changing the breakdown of voting rights: ( )
3. Full name of person(s) subject to the notification obligation (iii):
SAAD INVESTMENT COMPANY LIMITED
4. Full name of shareholder(s) (if different from 3.) (iv):
Vidacos Nominees Ltd
(Citigroup Global AWAL)
5. Date of the transaction and date on which the threshold is crossed or reached
if different) (v):
Not specified.
6. Date on which issuer notified:
12 February 2007
7. Threshold(s) that is/are crossed or reached:
.................
8. Notified details:
.................
A: Voting rights attached to shares
Class/type of shares Situation previous to
if possible using the the Triggering
ISIN CODE transaction (vi)
Number of shares Number of voting Rights
(viii)
Ordinary Not Not
Shares specified specified
Resulting situation after the triggering transaction (vii)
Class/type of shares Number of shares Number of voting rights % of voting rights
if possible using (ix)
the ISIN CODE
Direct Direct (x) Indirect (xi) Direct Indirect
Ordinary Shares 35,616,666 35,616,666 0 25.8788% 0
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial (xiii) Period/ Date (xiv) rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.
N/A - - - -
Total (A+B)
Number of voting rights % of voting rights
35,616,666 25.8788%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):
None specified.
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
Recent acquisition of 16,666,666 new ordinary shares as part of a placing
by the Company.
14. Contact name:
Michael Hunt, CEO
15. Contact telephone number:
01483 302560
Annex Notification Of Major Interests In Shares (XVI)
A: Identity of the person or legal entity subject to the notification obligation
Full name (including legal form for legal entities):
Saad Investment Company Limited
Contact address (registered office for legal entities):
80 rue de Lausanne, 1202 Geneva, Switzerland
Phone number:
+41 22 715 03 03
Other useful information (at least legal representative for legal persons):
-
B: Identity of the notifier, if applicable (xvii)
Full name:
N/A
Contact address:
N/A
Phone number:
N/A
Other useful information (e.g. functional relationship with the person or legal
entity subject to the notification obligation):
N/A
C: Additional information :
N/A
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.